Health economic impact of software-assisted brain MRI on therapeutic decision-making and outcomes of relapsing-remitting multiple sclerosis patients—a …
Aim: To develop a microsimulation model to assess the potential health economic impact of
software-assisted MRI in detecting disease activity or progression in relapsing-remitting …
software-assisted MRI in detecting disease activity or progression in relapsing-remitting …
Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison
Background: Alemtuzumab and natalizumab are approved as second-line therapies for
relapsing-remitting multiple sclerosis (RRMS) patients in Iran who have shown an …
relapsing-remitting multiple sclerosis (RRMS) patients in Iran who have shown an …